发明授权
- 专利标题: Arylsulfonamide CCR3 antagonists
- 专利标题(中): 芳基磺酰胺CCR3拮抗剂
-
申请号: US12764894申请日: 2010-04-21
-
公开(公告)号: US08420639B2公开(公告)日: 2013-04-16
- 发明人: Tai Wei Ly , Jared Andrew Forrester
- 申请人: Tai Wei Ly , Jared Andrew Forrester
- 申请人地址: US CA San Diego
- 专利权人: Axikin Pharmaceuticals, Inc.
- 当前专利权人: Axikin Pharmaceuticals, Inc.
- 当前专利权人地址: US CA San Diego
- 代理机构: Jones Day
- 主分类号: A61K31/5377
- IPC分类号: A61K31/5377 ; A61K31/495 ; A61K31/496 ; C07D241/04 ; C07D413/06 ; C07D401/06
摘要:
Provided herein are arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
公开/授权文献
- US20100273795A1 ARYLSULFONAMIDE CCR3 ANTAGONISTS 公开/授权日:2010-10-28